Hospital
ST. Joseph's Medical Center
ST. Joseph's Medical Center was paid $41.35M by Medicaid between Jan 2018 and Dec 2024, across 192 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 46% of everything it billed.
33Billing provider infoST. JOSEPH'S MEDICAL CENTER
BRAINERD, MN 56401
BRAINERD, MN 56401
33aNPI1568415974assigned 05/18/2006
33bProvider typeSubstance Use Disorder Rehabilitation Hospital Unit
28Total paid$41.35M
24GClaims638,813
24DCodes billed192
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Substance Use Disorder Rehabilitation Hospital Unit providers in Minnesota
Rank by total paid#1 of 5
Median peer was paid$938K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BOREN, KEVIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,434 | $2.19M | |
| 2019 | 95,078 | $5.95M | |
| 2020 | 72,120 | $4.31M | |
| 2021 | 106,722 | $6.69M | |
| 2022 | 98,627 | $6.51M | |
| 2023 | 96,954 | $7.64M | |
| 2024incomplete | 79,878 | $8.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 46% | 253,107 | 222,738 | $19.13M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 43,061 | 36,624 | $5.52M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.9% | 23,137 | 20,154 | $4.11M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.5% | 41,819 | 35,441 | $3.91M |
| G9002 | Coordinated care fee, maintenance rate | 8.9% | 16,178 | 16,067 | $3.67M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.0% | 15,000 | 12,940 | $1.23M |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 79,220 | 70,092 | $475K |
| 80053 | Comprehensive metabolic panel | <1% | 22,526 | 20,201 | $289K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 4,777 | 4,426 | $201K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,506 | 5,179 | $197K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,357 | 1,233 | $176K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29,900 | 26,094 | $150K |
180 more codes
| 99223 | Prolong inpt eval add15 m | <1% | 1,130 | $141K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,998 | $127K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 9,967 | $122K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 6,198 | $120K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,090 | $115K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 826 | $110K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,404 | $99K |
| 0240U | <1% | 792 | $99K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,283 | $88K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 596 | $87K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 849 | $74K |
| 92557 | <1% | 872 | $69K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,286 | $57K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 781 | $55K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,590 | $40K |
| 95117 | <1% | 1,922 | $38K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,020 | $37K |
| 0002A | <1% | 1,369 | $35K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,662 | $34K |
| 0001A | <1% | 1,353 | $32K | |
| 95886 | <1% | 253 | $30K | |
| 94060 | <1% | 216 | $29K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 54 | $29K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 251 | $28K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 649 | $26K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 38 | $25K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 218 | $24K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 312 | $24K |
| 71045 | Radiologic examination, chest; single view | <1% | 620 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,350 | $23K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,555 | $22K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,470 | $20K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 440 | $20K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,606 | $19K |
| 80061 | Lipid panel | <1% | 1,911 | $17K |
| 90686 | <1% | 1,733 | $17K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 798 | $14K |
| 11721 | <1% | 553 | $14K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 913 | $14K |
| H2035 | Alcohol and/or other drug treatment program, per hour | <1% | 473 | $14K |
| 86780 | <1% | 1,313 | $13K | |
| 85027 | <1% | 3,634 | $13K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 928 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 573 | $12K |
| 98929 | <1% | 267 | $11K | |
| 90836 | <1% | 359 | $10K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 524 | $10K |
| 59025 | Fetal non-stress test | <1% | 44 | $9K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 163 | $7K |
| Q3014 | Telehealth originating site facility fee | <1% | 658 | $7K |
| 91320 | <1% | 118 | $7K | |
| 92567 | <1% | 366 | $6K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 67 | $6K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 40 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 245 | $6K |
| 83605 | <1% | 834 | $6K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 4,534 | $5K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 72 | $5K |
| 98927 | <1% | 164 | $5K | |
| 0004A | <1% | 209 | $5K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 26 | $5K |
| 73630 | <1% | 265 | $5K | |
| 94729 | <1% | 197 | $5K | |
| 0124A | <1% | 205 | $5K | |
| 74019 | <1% | 229 | $5K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,213 | $4K |
| 97035 | <1% | 115 | $4K | |
| 0072A | <1% | 134 | $4K | |
| 0071A | <1% | 123 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,005 | $4K |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 720 | $4K |
| 90480 | <1% | 136 | $4K | |
| 94726 | <1% | 192 | $3K | |
| 81001 | <1% | 980 | $3K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 89 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 345 | $3K |
| 0011A | <1% | 108 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 62 | $3K |
| 0012A | <1% | 108 | $3K | |
| 84439 | <1% | 254 | $3K | |
| 96367 | <1% | 39 | $3K | |
| 85610 | <1% | 220 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,509 | $2K |
| 86803 | <1% | 279 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 95 | $2K |
| 86481 | <1% | 56 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 276 | $2K |
| 86140 | <1% | 607 | $2K | |
| 88142 | <1% | 133 | $2K | |
| 83690 | <1% | 456 | $2K | |
| 99220 | <1% | 17 | $2K | |
| 87340 | <1% | 329 | $2K | |
| 83655 | <1% | 178 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,170 | $1K |
| 87631 | <1% | 14 | $1K | |
| 99221 | <1% | 14 | $1K | |
| 97165 | <1% | 14 | $1K | |
| 0064A | <1% | 65 | $1K | |
| 12001 | <1% | 43 | $1K | |
| 0031A | <1% | 59 | $1K | |
| 0054A | <1% | 39 | $1K | |
| 86003 | <1% | 358 | $1K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 776 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,331 | $1K |
| 86850 | <1% | 142 | $937.96 | |
| 83735 | <1% | 336 | $934.33 | |
| 36416 | <1% | 399 | $910.36 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 469 | $889.50 |
| 99406 | <1% | 56 | $884.06 | |
| 88307 | <1% | 13 | $879.60 | |
| 97161 | <1% | 47 | $876.71 | |
| 81003 | <1% | 387 | $864.78 | |
| 99217 | <1% | 16 | $762.38 | |
| 86480 | <1% | 13 | $735.80 | |
| 84703 | <1% | 251 | $652.66 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 51 | $644.39 |
| 82607 | <1% | 88 | $622.92 | |
| 86900 | <1% | 77 | $574.12 | |
| 87081 | <1% | 774 | $572.71 | |
| 87510 | <1% | 99 | $548.60 | |
| 87480 | <1% | 99 | $534.11 | |
| 93296 | <1% | 39 | $531.82 | |
| 85652 | <1% | 169 | $492.72 | |
| 86704 | <1% | 56 | $453.77 | |
| 87660 | <1% | 99 | $451.85 | |
| 80076 | <1% | 42 | $435.00 | |
| 95012 | <1% | 131 | $433.61 | |
| 82565 | <1% | 85 | $427.90 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 75 | $418.39 |
| 84484 | <1% | 103 | $391.88 | |
| 87634 | <1% | 40 | $378.75 | |
| 51798 | <1% | 16 | $378.25 | |
| 86708 | <1% | 57 | $371.21 | |
| 90656 | <1% | 19 | $363.79 | |
| 82728 | <1% | 28 | $348.91 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 25 | $348.04 |
| 86706 | <1% | 57 | $324.82 | |
| 83516 | <1% | 135 | $286.45 | |
| 85018 | <1% | 43 | $265.73 | |
| 86901 | <1% | 77 | $242.60 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 15 | $232.18 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 70 | $227.56 |
| 82950 | <1% | 63 | $197.82 | |
| 86762 | <1% | 50 | $196.45 | |
| 84481 | <1% | 12 | $189.33 | |
| 84466 | <1% | 18 | $181.62 | |
| 96161 | <1% | 24 | $170.58 | |
| 96127 | <1% | 223 | $149.29 | |
| 88304 | <1% | 12 | $143.16 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $142.25 |
| 86235 | <1% | 77 | $118.18 | |
| 87420 | <1% | 43 | $115.12 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 106 | $110.74 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 25 | $110.00 |
| 90732 | <1% | 13 | $95.96 | |
| 80164 | <1% | 13 | $95.67 | |
| 83540 | <1% | 18 | $92.13 | |
| 73610 | <1% | 13 | $88.83 | |
| 84450 | <1% | 24 | $85.97 | |
| 94010 | <1% | 13 | $65.16 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 97 | $62.40 |
| 99188 | <1% | 72 | $59.10 | |
| 82947 | <1% | 14 | $52.48 | |
| 82248 | <1% | 29 | $50.62 | |
| 86255 | <1% | 25 | $42.42 | |
| 82784 | <1% | 41 | $29.41 | |
| 86200 | <1% | 18 | $21.22 | |
| 87186 | <1% | 53 | $20.59 | |
| 86225 | <1% | 26 | $15.15 | |
| 86431 | <1% | 19 | $14.65 | |
| 82550 | <1% | 30 | $13.64 | |
| 86038 | <1% | 26 | $13.64 | |
| 87077 | <1% | 44 | $9.75 | |
| 82077 | 0% | 15 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 62 | $0.00 |
| 90717 | 0% | 14 | $0.00 | |
| 90691 | 0% | 13 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 17 | $0.00 |
| 84550 | 0% | 19 | $0.00 | |
| 91300 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOREN, KEVIN (VP OF FINANCE)
Parent organizationESSENTIA HEALTH
| Provider | Location | Paid |
|---|---|---|
| The Duluth Clinic, LTD | Duluth, MN | $51.60M |
| SMDC Medical Center | Duluth, MN | $35.51M |
| ST Marys Medical Center | Duluth, MN | $20.98M |
| ST. Mary's Hospital of Superior | Superior, WI | $13.36M |
| ST Joseph's Medical Center | Baxter, MN | $7.23M |
| ST. Mary's Duluth Clinic Health System | Duluth, MN | $4.97M |
| Deer River Healthcare Center, INC. | Deer River, MN | $4.57M |
| ST. Mary's Medical Center | Duluth, MN | $3.66M |
| ST. Joseph's Medical Center | Brainerd, MN | $3.25M |
| The Duluth Clinic, LTD | Virginia, MN | $2.82M |
| The Duluth Clinic, LTD | Duluth, MN | $2.66M |
| Northern Pines Medical Center | Aurora, MN | $1.72M |
| ST. Mary's Hospital of Superior | Superior, WI | $1.65M |
| Polinsky Medical Rehabilitation Center | Duluth, MN | $1.61M |
| Pine Medical Center | Sandstone, MN | $1.32M |
| The Duluth Clinic, LTD | Hermantown, MN | $1.30M |
| The Duluth Clinic LTD | Grand Rapids, MN | $1.18M |
| The Duluth Clinic, LTD | Duluth, MN | $1.13M |
| The Duluth Clinic, LTD | Ashland, WI | $1.07M |
| ST Mary's Hospital of Superior | Spooner, WI | $1.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.